A single centre prospective cohort study addressing the effect of a rule-in/rule-out troponin algorithm on routine

Jack Marjot1, Thomas E Kaier1, Katherine Henderson2

  • 11 King's College London BHF Centre, St Thomas' Hospital, London, UK.

Insights

Implementing a rapid diagnostic algorithm for acute coronary syndromes using high-sensitivity troponin assays allows for quick patient triage. This strategy effectively rules out or in myocardial injury, improving emergency department workflows.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Diagnostics

Background:

  • New European Society of Cardiology guidelines (2015) recommend high-sensitivity troponin assays for diagnosing acute coronary syndromes without ST-segment elevation.
  • These guidelines utilize a '0 hour' blood test for rapid 'rule-in' and 'rule-out' of acute myocardial injury.
  • While validated in studies, the real-world impact of implementing these algorithms in clinical practice remains largely undescribed.

Purpose of the Study:

  • To describe the impact of implementing a high-sensitivity troponin rapid diagnostic algorithm on patient journeys in an inner-city Emergency Department.
  • To evaluate the effectiveness of the algorithm in routine clinical practice.

Main Methods:

  • Prospective data collection from electronic records at a large Central London hospital over seven months.
  • Analysis of high-sensitivity troponin T measurements and algorithm application before, during, and after implementation.
  • Tracking of patient triage and repeat testing patterns.

Main Results:

  • Over 213 days, 4644 patients underwent high-sensitivity troponin T testing.
  • 40.4% of patients were 'ruled-out' and 7.6% were 'ruled-in' at presentation.
  • A 37.5% increase in repeat high-sensitivity troponin T measurements within 1.5 hours was observed for 'intermediate risk' patients.

Conclusions:

  • The introduction of a 0-hour 'rule-in'/'rule-out' algorithm facilitates rapid triage for 48% of patients.
  • The algorithm is associated with expedited repeat testing for patients categorized as intermediate risk.
  • Implementation in routine practice streamlines the diagnostic pathway for acute myocardial injury.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
543
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
939